Initial Use of Echinocandins Does Not Negatively Influence Outcome in Candida parapsilosis Bloodstream Infection: A Propensity Score Analysis
2014; Oxford University Press; Volume: 58; Issue: 10 Linguagem: Inglês
10.1093/cid/ciu158
ISSN1537-6591
AutoresMario Fernández‐Ruiz, José María Aguado, Benito Almirante, David Lora, Belén Padilla, Mireia Puig‐Asensio, Miguel Montejo, Julio García‐Rodríguez, Javier Pemán, Maite Ruiz Pérez de Pipaón, Manuel Cuenca‐Estrella, Belén Padilla, Patricia Muñóz, Jesús Guinea, José Ramón Paño Pardo, Julio García‐Rodríguez, Carlos García-Cerrada, Jesús Fortün, Pilar Matía-Martín, Elia Gómez, Pablo Ryan, Carolina Campelo, Ignacio de los Santos, Ventura Buendía, B. Pérez Gorricho, Mercedes Alonso, Francisca Sanz, José María Aguado, Paloma Merino, Fernando González Romo, Miguel Górgolas, Ignacio Gadea, Juan Emilio Losa, Alberto Delgado‐Iribarren, António Ramos, Yolanda Romero, Isabel Sánchez Romero, Óscar Zaragoza, Manuel Cuenca‐Estrella, Jesús Rodríguez‐Baño, Ana Isabel Suárez, Ana Loza, Ana Isabel Aller García, Estrella Martín‐Mazuelos, Maite Ruiz Pérez de Pipaón, José Garnacho, Carlos Ortíz, Mónica Chávez, F.L. Maroto, Miguel Salavert, Javier Pemán, José Blanquer, David Navarro, Juan J. Camarena, Rafael Zaragoza, Vicente Abril, Concepción Gimeno, Silvia Hernáez, Guillermo Ezpeleta, Elena Bereciartúa, J.L. Hernández Almaraz, Miguel Montejo, R.A. Rivas, R. Ayarza, Ana Ma Planes, Isabel Ruiz‐Camps, Benito Almirante, José Mensa, Manel Almela, Mercè Gurguí, F Sánchez, Joaquin Martínez‐Montauti, Montserrat Sierra, Juan Pablo Horcajada, Luisa Sorlí, Julià Gómez, Amadeu Gené, Mireia Urrea, Maricela Valerio, Ana Díaz‐Martín, Francesc Puchades Gimeno, Alessandra Mularoni,
Tópico(s)Cystic Fibrosis Research Advances
ResumoIn patients with Candida parapsilosis candidemia, the use of an echinocandin-based regimen for the first 72 hours of therapy had no impact on the odds for clinical failure, despite the lower in vitro activity of this class of antifungals.
Referência(s)